LDLc reduction with fixed-dose combination rosuvastatin-ezetimibe in patients with coronary heart disease that are not candidates for PCSK9 inhibitors treatment
27 August 2021 (08:00 - 20:00)
Organised by:
Abstract
Slides
About the speaker
Hospital San Juan de Alicante, Alicante (Spain)
224 More presentations in this session
Doctor B. Keskin Meric (London, GB)
Doctor R. Ong (Makati, PH)
Mr R. Gascuena (Leganes, ES)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
27 August 2021
08:00 CET
